Daniel Joseph McCarthy - Aug 22, 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
PRESIDENT
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Aug 22, 2024
Transactions value $
-$958,186
Form type
4
Date filed
8/26/2024, 08:16 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $113K +4.55K +2.09% $24.75 223K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$501K -16.7K -7.5% $30.00 206K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$231K -7K -3.4% $33.00 199K Aug 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$207K -6.47K -3.25% $32.00 192K Aug 23, 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale -$132K -4K -2.08% $33.00 188K Aug 23, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -4.55K -100% $0.00 0 Aug 22, 2024 Class A Common Stock 4.55K $24.75 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on August 1, 2018, August 1, 2019, August 1, 2020, and August 1, 2021.